5 Key Takeaways

• 1

  Geographic atrophy (GA) is a challenging form of age-related macular degeneration requiring careful management.

• 2

  Patient selection for intravitreal injections is based on phenotype and imaging biomarkers indicating high risk of vision loss.

• 3

  Education and engagement of patients are crucial for adherence to treatment and improving outcomes in GA management.

• 4

  Safety protocols are essential during intravitreal injections to mitigate risks such as retinal vasculitis and intraocular inflammation.

• 5

  A coordinated approach involving patient selection, education, and safety measures enhances GA management and patient quality of life.